Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Illumina, Inc., a leader in the research and development services sector, is headquartered in the United States and operates globally, with significant presence in Europe and Asia. Founded in 1998, Illumina has revolutionised genomics through its innovative sequencing and array-based solutions, enabling advancements in personalised medicine and genetic research.
The company’s core products, including next-generation sequencing (NGS) systems and genomic analysis tools, are distinguished by their high throughput and accuracy, making them essential for researchers and healthcare providers. Illumina's commitment to advancing genomic technology has positioned it as a market leader, with notable achievements such as the development of the NovaSeq series, which has set new standards in sequencing efficiency. Through its pioneering efforts, Illumina continues to drive significant advancements in the life sciences industry.
+44 vs industry average
Illumina’s score of 77 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Illumina, a US-based company in the research and development services industry, reported its 2024 carbon emissions. Its Scope 1 emissions were 18,836,000 kg CO2e, and its Scope 2 emissions (location-based) were 21,224,000 kg CO2e. Scope 3 emissions were approximately 241,938,000 kg CO2e, with significant contributions from upstream transportation and distribution (97,472,000 kg CO2e), purchased goods and services (62,264,000 kg CO2e), and capital goods (37,194,000 kg CO2e).
Illumina has set ambitious climate commitments validated by the Science Based Targets initiative (SBTi). The company aims to achieve net-zero greenhouse gas emissions across its direct operations (Scope 1 and 2) and value chain (Scope 3) by 2050, from a 2019 baseline.
Near-term targets include:
Long-term targets, also from a 2019 base year, include:
For fiscal years 2022, 2023, and 2024, Illumina reported a 100% reduction in Scope 1 and 2 emissions from its 2019 baseline, exceeding its SBTi targets through mitigation efforts including carbon offsets for natural gas Scope 1 and a combination of on-site solar, purchased renewable electricity, and renewable electricity credits for Scope 2.
2050
90% reduction in scope 3 total
Illumina, Inc. commits to reduce absolute scope 3 emissions from purchased goods and services, capital goods, upstream transportation and di…
2050
90% reduction in Scope 2
Illumina, Inc. commits to reduce absolute scope 2 GHG emissions 90% by 2050 from a 2019 base year.
2030
46% reduction in Scope 2
Illumina, Inc. commits to reduce absolute scope 2 GHG emissions 46% by 2030 from a 2019 base year.
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Illumina’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more